Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Amines Stories

2013-08-29 12:26:31

TORONTO, Aug. 29, 2013 /CNW/ - UCB Canada Inc. announced today that NEUPRO® (rotigotine) is now available in Canada for the treatment of Parkinson's disease. The availability of NEUPRO® in Canada follows Health Canada's approval in March, making it the first new treatment for Parkinson's disease approved in Canada in five years.  NEUPRO® is the first and only non-ergolinic dopamine agonist available in a patch, and provides 24-hour delivery of rotigotine through the skin...

2013-08-21 23:20:46

Cultivation approval from USDA - mid-decade launch planned with a new mode of action: tolerance to isoxaflutole and glyphosate herbicides Research Triangle Park, N.C. (PRWEB) August 21, 2013 Bayer CropScience and MS Technologies LLC have achieved a milestone on their path to delivering new solutions for soybean farmers. The dual herbicide tolerance trait Balance™ GT (Event FG72) has received cultivation approval from the U.S. Department of Agriculture (USDA). This step follows approval...

2013-08-21 08:26:19

ATLANTA, Aug. 21, 2013 /PRNewswire/ -- Atlantic Pharmaceuticals, Inc., today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,507,001 that contains claims which cover Atlantic's SMART/Script(TM) abuse deterrent drug delivery system. SMART/Script(TM) is designed to prevent dose dumping of orally delivered prescription opioids and may sequester and reduce drug release of a pharmaceutical that has been subjected to a variety of physical...

2013-08-20 23:29:32

Prescription Drug abuse is on the rise with over 100 people that die every day from drug overdoses in the United States, a number that has more than tripled since 1990. The specialists at Treatment Center Finder focus on the specific needs of the addict that need to be met for successful treatment. Pompano Beach, FL (PRWEB) August 20, 2013 In an article published August 12th, 2013 by NBC, Dr. Joseph Sirven discussed the growing epidemic that is plaguing the US, Prescription Drug abuse....

2013-08-08 20:21:07

SANTA BARBARA, Calif., Aug. 8, 2013 /PRNewswire/ -- VG Energy, an agricultural biotech company and wholly owned subsidiary of publicly traded VG Life Sciences Inc. (VGLS), announces today a $200,000 competitive grant from the Texas A&M AgriLife Research BioEnergy Initiatives Program for testing oil secretion technology. The Texas A&M AgriLife Research Bioenergy Initiatives Program awarded the $200,000 grant to Dr. Marty Dickman, Chief Scientist at VG Energy, and Dr. Paul de...

2013-08-07 10:44:28

New findings could lead to drugs that fight back when tumors don't respond to treatment Cancer drugs known as ErbB inhibitors have shown great success in treating many patients with lung, breast, colon and other types of cancer. However, ErbB drug resistance means that many other patients do not respond, and even among those who do, tumors commonly come back. A new study from MIT reveals that much of this resistance develops because a protein called AXL helps cancer cells to circumvent...

2013-08-06 23:26:58

True-Dose Pets will bring its all-natural pet supplement to the Cardinal Health Pharmacy Retail Business Conference August 7-10 in Seattle, Washington. Saint Louis, MO (PRWEB) August 06, 2013 True-Dose Pets will bring its best-selling natural pet products to the Cardinal Health Pharmacy Retail Business Conference. True-Dose pet supplements have swept through hundreds of Cardinal pharmacies in the past few months, and the RBC conference provides the opportunity for the True-Dose team to...

2013-08-06 23:26:56

PAINWeek designates September 6 as “Opioid Safety Day,” and will present a 90-minute session, “The Great Divide: the Debate on Long-Term Opioid Prescribing for Chronic Noncancer Pain” at the national conference. The expert panel will offer an expansive discussion that addresses numerous perspectives in this ongoing controversy. Montclair, NJ (PRWEB) August 06, 2013 PAINWeek, the National Conference on Pain for Frontline Practitioners, has designated Friday, September 6, as...

2013-08-01 12:25:59

Through 2022, New Drug Launches Will Not Offset Market Decline Caused By Expanding Generic Competition Among Antidepressants and Antipsychotics, According to a New Report from Decision Resources BURLINGTON, Mass., Aug. 1, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that Lundbeck/Takeda Pharmaceutical's emerging antidepressant Brintellix will attain blockbuster status for unipolar...

2013-07-31 23:32:02

National health advisor says risk not taking because of higher rate of birth defects. Resource4thePeople's national network of attorneys continues to offer free consultations to provide possible legal options to families of children allegedly suffering birth defects after use of antidepressants during pregnancies. San Diego, CA (PRWEB) July 31, 2013 http://www.resource4thepeople.com/defectivedrugs/SSRI-Birth-Defects.html Resource4thePeople announced today its latest update about the...